Comparing Self-Reported Presenteeism with Objectively Measured Direct and Indirect Costs, Lost Time and Comorbidity Assessments for Employees with Cancer
Author(s)
Brook R1, Beren IA2, Kleinman NL2, Drnach AA3, Schaneman JA2, Rosenberg EM3
1Better Health WW/NPRT/NASP, Newfoundland, NJ, USA, 2Workpartners, LLC, Loveland, CO, USA, 3Workpartners, LLC, Pittsburgh, PA, USA
OBJECTIVES: Assess whether self-assessed presenteeism (SAP) matches objectively measured costs and absences for employees with cancer and the relationship between medical-costs and the Charlson Comorbidity Index (CCI).
METHODS: Retrospective analysis using Workpartners RRDb (2012—2019). For each year, employees who completed the Health Productivity Questionnaire [HPQ] or WebMDs’ SAP survey were checked for claims with ICD-9s/-10s within the US Agency for Healthcare Research and Quality’s cancer categories. Employees had continuous eligibility for the calendar-year they completed a SAP-survey and were included each year eligible. Analysis focused on #of employees completing the survey, with the condition, and each cancer-cohorts’ medical and prescription costs, lost days and costs [leaves for: sick leave (SL), short-/long-term disability (STD/LTD), and workers’ compensation (WC)], and CCI. Condition-based information is reported as %of cancer category. Claims start in the year initiated.
RESULTS: SAP for cancer conditions ranged from 10.4%±0.6% (cancer of the uteris,N=378)—16.3%±1.2% (cancer of the testis,N=138). Despite the highest SAP, employees with cancer of the testis had low medical and drug costs (both <31% of average), few absences (below avg SL,no LTD-claims, STD (costs&days) <20%, and <5% of WC-costs [no WC-days]). Cancer of the cervix (SAP=13.3%±0.2%,N=4758) and breast (SAP=10.8%±0.2%,N=3293) were the most common with SAPs in the Workpartners RRDb 32% and 22.2%, respectively and below average for all costs/days except WC (costs,days) which were (174.2% of costs,171.3% of days) for cancer of the cervix and (122.6% of costs,192.2% of days) for breast cancer. Employees with pancreatic cancer had the 2nd highest CCI (6.11±0.5,181.7% of avg), the highest medical (200.8%),3rd highest prescription-costs (195.1%) and in the middle of SAP(13.3%±1.5%). SL was highest for cancer of GI organs in both days (26.9±2.1) and costs ($6819±$740). CCI correlated (P<0.0001) with medical-costs [Spearman's=0.3446, higher by Pearson's=0.3849].
CONCLUSIONS: SAP scores among employees with cancer conditions do not always reflect the objective (cost or absence) impact.
Conference/Value in Health Info
Value in Health, Volume 25, Issue 6, S1 (June 2022)
Code
RWD108
Topic
Economic Evaluation, Real World Data & Information Systems
Topic Subcategory
Health & Insurance Records Systems, Work & Home Productivity - Indirect Costs
Disease
Oncology